Pseudomyxoma peritonei natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 3: Line 3:
{{CMG}}{{AE}}{{Nnasiri}}{{PSD}}
{{CMG}}{{AE}}{{Nnasiri}}{{PSD}}
==Overview==
==Overview==
Pseudomyxoma peritonei is a rare disease characterized by the accumulation of [[mucinous]] ascites and mucinous tumor disseminated in the [[peritoneal]] cavity, mainly [[abdomen]] and [[pelvis]]; the disease mainly originates from primary appendiceal tumors and less commonly from the [[ovary]] and [[colon]]. In 2010, WHO published a classification which divides pseudomyxoma peritonei (PMP) into low and high grades. Cytoreductive surgery with [[hyperthermic intraperitoneal chemoperfusion]] (CRS/HIPEC) is the mainstay of treatment appendiceal pseudomyxoma peritonei (PMP).
Pseudomyxoma peritonei is a rare disease characterized by the accumulation of [[mucinous]] [[ascites]] and [[mucinous]] [[tumor]] disseminated in the [[peritoneal]] cavity, mainly the [[abdomen]] and [[pelvis]]. The disease mainly originates from primary [[Appendiceal cancers|appendiceal tumors]] and less commonly from the [[ovary]] and [[colon]]. In 2010, WHO published a classification which divides pseudomyxoma peritonei (PMP) into low and high grades. Cytoreductive surgery with [[hyperthermic intraperitoneal chemoperfusion]] (CRS/HIPEC) is the mainstay of treatment [[Appendiceal cancers|appendiceal]] pseudomyxoma peritonei (PMP).


==Natural History==
==Natural History==
*Pseudomyxoma peritonei (PMP) is an uncommon disease characterized by mucinous [[ascites]] in intraperitoneal cavities, it is originating from a low-grade mucinous neoplasm of the [[appendix]], if left untreated, patients with pseudomyxoma peritonei may progress to develop [[abdominal]] or [[pelvic]] pain, [[bloating]], [[abdominal distension]], [[weight change]], pelvic mass and [[infertility]] due to compression impact of tumor on [[visceral]] organs.<ref name="pmid29326943">{{cite journal |vauthors=Pugin F, Bouquet De Jolinière J, Major A, Khomsi F, Guillou L, Peter M, Ben Ali N, Egger B, Feki A |title=Pseudomyxoma Peritonei: A Case Report Diagnosed in a 47-Year-Old Woman with Chronic Pelvic Abdominal Pain and Appendicular Origin: Review of the Literature and Management |journal=Front Surg |volume=4 |issue= |pages=41 |date=2017 |pmid=29326943 |pmc=5741642 |doi=10.3389/fsurg.2017.00041 |url=}}</ref>  
*Pseudomyxoma peritonei (PMP) is an uncommon disease characterized by [[mucinous]] [[ascites]] in [[intraperitoneal]] cavities, originating from a low-grade [[mucinous]] [[neoplasm]] of the [[appendix]]. If left untreated, patients with pseudomyxoma peritonei may progress to develop [[abdominal]] or [[pelvic]] pain, [[bloating]], [[abdominal distension]], [[weight change]], [[Pelvic masses|pelvic mass]] and [[infertility]] due to compression impact of tumor on [[visceral]] [[Organ (anatomy)|organs]].<ref name="pmid29326943">{{cite journal |vauthors=Pugin F, Bouquet De Jolinière J, Major A, Khomsi F, Guillou L, Peter M, Ben Ali N, Egger B, Feki A |title=Pseudomyxoma Peritonei: A Case Report Diagnosed in a 47-Year-Old Woman with Chronic Pelvic Abdominal Pain and Appendicular Origin: Review of the Literature and Management |journal=Front Surg |volume=4 |issue= |pages=41 |date=2017 |pmid=29326943 |pmc=5741642 |doi=10.3389/fsurg.2017.00041 |url=}}</ref>  
*The tumor produces abundant mucins which accumulate because of gravity effect in the [[mesentery]], the greater and [[lesser omentum]], and under the [[diaphragm]], around the [[liver]] and other [[visceral]] organs surfaces.<ref name="LevyShaw2009">{{cite journal|last1=Levy|first1=Angela D.|last2=Shaw|first2=Janet C.|last3=Sobin|first3=Leslie H.|title=Secondary Tumors and Tumorlike Lesions of the Peritoneal Cavity: Imaging Features with Pathologic Correlation|journal=RadioGraphics|volume=29|issue=2|year=2009|pages=347–373|issn=0271-5333|doi=10.1148/rg.292085189}}</ref>  
*The [[tumor]] produces abundant [[Mucin|mucins]] which accumulate because of gravity effect in the [[mesentery]], the greater and [[lesser omentum]], under the [[diaphragm]], around the [[liver]] and other [[visceral]] [[Organ (anatomy)|organ]] surfaces.<ref name="LevyShaw2009">{{cite journal|last1=Levy|first1=Angela D.|last2=Shaw|first2=Janet C.|last3=Sobin|first3=Leslie H.|title=Secondary Tumors and Tumorlike Lesions of the Peritoneal Cavity: Imaging Features with Pathologic Correlation|journal=RadioGraphics|volume=29|issue=2|year=2009|pages=347–373|issn=0271-5333|doi=10.1148/rg.292085189}}</ref>  
*The optimal treatment is cytoreductive surgery (CRS) combined with [[hyperthermic intraperitoneal chemoperfusion]] (HIPEC).<ref name="pmid28540829">{{cite journal |vauthors=Mittal R, Chandramohan A, Moran B |title=Pseudomyxoma peritonei: natural history and treatment |journal=Int J Hyperthermia |volume=33 |issue=5 |pages=511–519 |date=August 2017 |pmid=28540829 |doi=10.1080/02656736.2017.1310938 |url=}}</ref>
*The optimal treatment is cytoreductive surgery (CRS) combined with [[hyperthermic intraperitoneal chemoperfusion]] (HIPEC).<ref name="pmid28540829">{{cite journal |vauthors=Mittal R, Chandramohan A, Moran B |title=Pseudomyxoma peritonei: natural history and treatment |journal=Int J Hyperthermia |volume=33 |issue=5 |pages=511–519 |date=August 2017 |pmid=28540829 |doi=10.1080/02656736.2017.1310938 |url=}}</ref>


==Prognosis==
==Prognosis==
*Prognosis of pseudomyxoma peritonei is generally good because of change in treatment modalities, traditional [[debulking]] surgery replaced by cytoreductive surgery combined with [[hyperthermic intraperitoneal chemoperfusion]] (HIPEC).<ref name="pmid11373099">{{cite journal |vauthors=Sugarbaker PH |title=Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome |journal=Eur J Surg Oncol |volume=27 |issue=3 |pages=239–43 |date=April 2001 |pmid=11373099 |doi=10.1053/ejso.2000.1038 |url=}}</ref>
*[[Prognosis]] of pseudomyxoma peritonei is generally good because of change in treatment modalities, traditional [[debulking]] [[surgery]] has been replaced by cytoreductive surgery combined with [[hyperthermic intraperitoneal chemoperfusion]] (HIPEC).<ref name="pmid11373099">{{cite journal |vauthors=Sugarbaker PH |title=Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome |journal=Eur J Surg Oncol |volume=27 |issue=3 |pages=239–43 |date=April 2001 |pmid=11373099 |doi=10.1053/ejso.2000.1038 |url=}}</ref>
*According to [[WHO]] classification, pseudomyxoma peritonei (PMP) divides into disseminated peritoneal adenomucinosis (DPAM) and peritoneal mucinous carcinomatosis (PMCA), with DPAM type having better prognosis with higher [[Survival rates|survival rate]] based on their histological [[morphology]], in contrast, tumors arising from [[colorectal]] [[neoplasm]] are usually high grades with bad prognosis.<ref name="CarrFinch2012">{{cite journal|last1=Carr|first1=Norman J|last2=Finch|first2=Jenny|last3=Ilesley|first3=Ian Charles|last4=Chandrakumaran|first4=Kandiah|last5=Mohamed|first5=Faheez|last6=Mirnezami|first6=Alex|last7=Cecil|first7=Tom|last8=Moran|first8=Brendan|title=Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases|journal=Journal of Clinical Pathology|volume=65|issue=10|year=2012|pages=919–923|issn=0021-9746|doi=10.1136/jclinpath-2012-200843}}</ref><ref name="pmid15048674">{{cite journal |vauthors=Mohamed F, Gething S, Haiba M, Brun EA, Sugarbaker PH |title=Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process |journal=J Surg Oncol |volume=86 |issue=1 |pages=10–5 |date=April 2004 |pmid=15048674 |doi=10.1002/jso.20038 |url=}}</ref><ref name="pmid7503361">{{cite journal |vauthors=Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM |title=Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei" |journal=Am. J. Surg. Pathol. |volume=19 |issue=12 |pages=1390–408 |date=December 1995 |pmid=7503361 |doi= |url=}}</ref>
*According to [[WHO]] classification, pseudomyxoma peritonei (PMP) is divided into disseminated peritoneal adenomucinosis (DPAM) and peritoneal mucinous carcinomatosis (PMCA), with DPAM type having better [[prognosis]] with higher [[Survival rates|survival rate]] based on their [[Histology|histological]] [[morphology]]. In contrast, [[Tumor|tumors]] arising from [[colorectal]] [[neoplasm]] are usually high grade with a bad [[prognosis]].<ref name="CarrFinch2012">{{cite journal|last1=Carr|first1=Norman J|last2=Finch|first2=Jenny|last3=Ilesley|first3=Ian Charles|last4=Chandrakumaran|first4=Kandiah|last5=Mohamed|first5=Faheez|last6=Mirnezami|first6=Alex|last7=Cecil|first7=Tom|last8=Moran|first8=Brendan|title=Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases|journal=Journal of Clinical Pathology|volume=65|issue=10|year=2012|pages=919–923|issn=0021-9746|doi=10.1136/jclinpath-2012-200843}}</ref><ref name="pmid15048674">{{cite journal |vauthors=Mohamed F, Gething S, Haiba M, Brun EA, Sugarbaker PH |title=Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process |journal=J Surg Oncol |volume=86 |issue=1 |pages=10–5 |date=April 2004 |pmid=15048674 |doi=10.1002/jso.20038 |url=}}</ref><ref name="pmid7503361">{{cite journal |vauthors=Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM |title=Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei" |journal=Am. J. Surg. Pathol. |volume=19 |issue=12 |pages=1390–408 |date=December 1995 |pmid=7503361 |doi= |url=}}</ref>


==References==
==References==

Latest revision as of 13:17, 2 April 2019

Pseudomyxoma peritonei Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pseudomyxoma peritonei from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pseudomyxoma peritonei natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudomyxoma peritonei natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pseudomyxoma peritonei natural history, complications and prognosis

CDC on Pseudomyxoma peritonei natural history, complications and prognosis

Pseudomyxoma peritonei natural history, complications and prognosis in the news

Blogs on Pseudomyxoma peritonei natural history, complications and prognosis

Directions to Hospitals Treating Pseudomyxoma peritonei

Risk calculators and risk factors for Pseudomyxoma peritonei natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]Parminder Dhingra, M.D. [3]

Overview

Pseudomyxoma peritonei is a rare disease characterized by the accumulation of mucinous ascites and mucinous tumor disseminated in the peritoneal cavity, mainly the abdomen and pelvis. The disease mainly originates from primary appendiceal tumors and less commonly from the ovary and colon. In 2010, WHO published a classification which divides pseudomyxoma peritonei (PMP) into low and high grades. Cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion (CRS/HIPEC) is the mainstay of treatment appendiceal pseudomyxoma peritonei (PMP).

Natural History

Prognosis

References

  1. Pugin F, Bouquet De Jolinière J, Major A, Khomsi F, Guillou L, Peter M, Ben Ali N, Egger B, Feki A (2017). "Pseudomyxoma Peritonei: A Case Report Diagnosed in a 47-Year-Old Woman with Chronic Pelvic Abdominal Pain and Appendicular Origin: Review of the Literature and Management". Front Surg. 4: 41. doi:10.3389/fsurg.2017.00041. PMC 5741642. PMID 29326943.
  2. Levy, Angela D.; Shaw, Janet C.; Sobin, Leslie H. (2009). "Secondary Tumors and Tumorlike Lesions of the Peritoneal Cavity: Imaging Features with Pathologic Correlation". RadioGraphics. 29 (2): 347–373. doi:10.1148/rg.292085189. ISSN 0271-5333.
  3. Mittal R, Chandramohan A, Moran B (August 2017). "Pseudomyxoma peritonei: natural history and treatment". Int J Hyperthermia. 33 (5): 511–519. doi:10.1080/02656736.2017.1310938. PMID 28540829.
  4. Sugarbaker PH (April 2001). "Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome". Eur J Surg Oncol. 27 (3): 239–43. doi:10.1053/ejso.2000.1038. PMID 11373099.
  5. Carr, Norman J; Finch, Jenny; Ilesley, Ian Charles; Chandrakumaran, Kandiah; Mohamed, Faheez; Mirnezami, Alex; Cecil, Tom; Moran, Brendan (2012). "Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases". Journal of Clinical Pathology. 65 (10): 919–923. doi:10.1136/jclinpath-2012-200843. ISSN 0021-9746.
  6. Mohamed F, Gething S, Haiba M, Brun EA, Sugarbaker PH (April 2004). "Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process". J Surg Oncol. 86 (1): 10–5. doi:10.1002/jso.20038. PMID 15048674.
  7. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM (December 1995). "Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei"". Am. J. Surg. Pathol. 19 (12): 1390–408. PMID 7503361.


Template:WikiDoc Sources